# Chemotherapy Combined With CIK Treating Colon Cancer

> **NCT03084809** · PHASE4 · COMPLETED · sponsor: **China Meitan General Hospital** · enrollment: 46 (actual)

## Conditions studied

- Colorectal Cancer
- Cytokine-induced Killer Cells
- Postoperative Complications
- Survival

## Interventions

- **DRUG:** Cytokine-induced killer cells+ FOLFOX4
- **DRUG:** FOLFOX4

## Key facts

- **NCT ID:** NCT03084809
- **Lead sponsor:** China Meitan General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05-06
- **Primary completion:** 2014-09-15
- **Final completion:** 2014-09-15
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2017-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03084809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03084809, "Chemotherapy Combined With CIK Treating Colon Cancer". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT03084809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*